Skip to main content

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Investor Securities Class Action Lawsuit 04/15/2022

  • If you purchased a shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), you have certain options and for certain investors are short and strict deadlines running. Deadline: June 14, 2022. NASDAQ: AUPH investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

May 22, 2023 - An amended complaint was filed. April 15, 2022 - An investor in shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Aurinia Pharmaceuticals Inc. in connection with certain allegedly false and misleading statements made between May 7, 20...



You must register (for free) or login to view the entire case.